121 related articles for article (PubMed ID: 26907614)
1. Plasma Angiotensin-(1-7) is a Potential Biomarker for Alzheimer's Disease.
Jiang T; Tan L; Gao Q; Lu H; Zhu XC; Zhou JS; Zhang YD
Curr Neurovasc Res; 2016; 13(2):96-9. PubMed ID: 26907614
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
[TBL] [Abstract][Full Text] [Related]
3. Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
Hisatake S; Kiuchi S; Kabuki T; Oka T; Dobashi S; Ikeda T
Heart Vessels; 2017 Mar; 32(3):303-308. PubMed ID: 27421979
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme serum activities: Relationship with Alzheimer's disease.
Zhuang S; Wang X; Wang HF; Li J; Wang HY; Zhang HZ; Xing CM
Brain Res; 2016 Nov; 1650():196-202. PubMed ID: 27608957
[TBL] [Abstract][Full Text] [Related]
5. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R
J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636
[TBL] [Abstract][Full Text] [Related]
6. Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia.
Mohite S; de Campos-Carli SM; Rocha NP; Sharma S; Miranda AS; Barbosa IG; Salgado JV; Simoes-E-Silva AC; Teixeira AL
Schizophr Res; 2018 Dec; 202():50-54. PubMed ID: 29925475
[TBL] [Abstract][Full Text] [Related]
7. Effect of hypertension on angiotensin-(1-7) levels in rats with different angiotensin-I converting enzyme polymorphism.
Ocaranza MP; Palomera C; Román M; Bargetto J; Lavandero S; Jalil JE
Life Sci; 2006 Feb; 78(14):1535-42. PubMed ID: 16229862
[TBL] [Abstract][Full Text] [Related]
8. Combining select neuropsychological assessment with blood-based biomarkers to detect mild Alzheimer's disease: a molecular neuropsychology approach.
Edwards M; Balldin VH; Hall J; O'Bryant S
J Alzheimers Dis; 2014; 42(2):635-40. PubMed ID: 24916542
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.
Wang T; Xiao S; Liu Y; Lin Z; Su N; Li X; Li G; Zhang M; Fang Y
Int J Geriatr Psychiatry; 2014 Jul; 29(7):713-9. PubMed ID: 24318929
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.
Rocha NP; Toledo A; Corgosinho LTS; de Souza LC; Guimarães HC; Resende EPF; Braz NFT; Gomes KB; Simoes E Silva AC; Caramelli P; Teixeira AL
J Alzheimers Dis; 2018; 64(4):1085-1090. PubMed ID: 30040721
[TBL] [Abstract][Full Text] [Related]
11. Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype.
Velloso EP; Vieira R; Cabral AC; Kalapothakis E; Santos RA
Braz J Med Biol Res; 2007 Apr; 40(4):583-90. PubMed ID: 17401503
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study.
Garg M; Burrell LM; Velkoska E; Griggs K; Angus PW; Gibson PR; Lubel JS
J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):559-69. PubMed ID: 24505094
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer's Disease.
Jiang T; Zhang YD; Zhou JS; Zhu XC; Tian YY; Zhao HD; Lu H; Gao Q; Tan L; Yu JT
Mol Neurobiol; 2016 May; 53(4):2489-97. PubMed ID: 26044748
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease.
Hsu JL; Lee WJ; Liao YC; Wang SJ; Fuh JL
Alzheimers Res Ther; 2017 Nov; 9(1):91. PubMed ID: 29169407
[TBL] [Abstract][Full Text] [Related]
15. Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141-147 in Taiwanese with Alzheimer's disease.
Lin CY; Sheu JJ; Tsai IS; Wang ST; Yang LY; Hsu IU; Chang HW; Lee HM; Kao SH; Lee CK; Chen CH; Lin YF
Clin Biochem; 2018 Jun; 56():75-82. PubMed ID: 29680706
[TBL] [Abstract][Full Text] [Related]
16. Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease.
Yakushev I; Muller MJ; Buchholz HG; Lang U; Rossmann H; Hampel H; Schreckenberger M; Fellgiebel A
Curr Alzheimer Res; 2012 Feb; 9(2):241-7. PubMed ID: 22044023
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
Goldknopf IL; Park HR; Sabbagh M
Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
[TBL] [Abstract][Full Text] [Related]
18. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
[TBL] [Abstract][Full Text] [Related]
19. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Andreasson U; Zetterberg H; Blennow K;
JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
[TBL] [Abstract][Full Text] [Related]
20. Influence of gender and genetic variability on plasma angiotensin peptides.
Reyes-Engel A; Morcillo L; Aranda FJ; Ruiz M; Gaitan MJ; Mayor-Olea A; Aranda P; Ferrario CM
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):92-7. PubMed ID: 17083063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
